There was a statistical significant difference in PAI-1 plasma levels between subjects with T2DM plus the Metabolic Syndrome and the reference group (58.4 ± 21 versus 49.9 ± 16 ng/mL, p = 0.026) Figure 1. This evidence concerns the gene SERPINE1 and metabolic syndrome.